HAJI MEDICINE CO.
Pharmaceutical company · 28 brands · 32 molecules
Ranked #169 of 207 companies in Quinolone Antibacterials
Company overview
HAJI MEDICINE CO. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 28 product registrations across 32 distinct molecules. Its portfolio is concentrated in Quinolone Antibacterials and Antithrombotic Agents. DRAP has issued 1 alert involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Top molecules by brand count
Therapeutic classes
Conditions treated
Price band (DRAP official ceilings)
Regulatory record
1 alert in the DRAP feed we track.
Competitive set
Companies whose registered portfolio overlaps most with this one.
Get the full profile for HAJI
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.
Request this brief See what’s included